Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Fish	O
derived	O
Attending:	O
___.	O
Chief	O
Complaint:	O
fever	O
and	O
neutropenia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
female	O
with	O
pancreatic	O
adenocarcinoma	O
s/p	O
biliary	O
stent	O
placement	O
and	O
diagnostic	O
laparoscopy	O
and	O
PAC	O
placement,	O
now	O
on	O
FOLFIRINOX	O
(started	O
___	O
with	O
planned	O
radiation	O
admitted	O
from	O
clinic	O
with	O
neutropenic	O
fever.	O
Presents	O
today	O
with	O
fever	O
and	O
leukopenia	O
from	O
her	O
___	O
clinic	O
where	O
she	O
was	O
seen	O
by	O
Dr	O
___.	O
Patient	O
endorses	O
worsening	O
fatigue,	O
lethargy	O
however	O
she	O
denies	O
localizing	O
symptoms	O
such	O
as	O
cough,	O
urinary	O
frequency,	O
dysuria,	O
flank	O
pain,	O
back	O
pain,	O
neck	O
pain,	O
headache,	O
abdominal	O
pain,	O
nausea,	O
vomiting.	O
She	O
has	O
had	O
ongoing	O
diarrhea	O
in	O
the	O
setting	O
of	O
chemotherapy.	O
She	O
endorses	O
chills.	O
She	O
was	O
recently	O
evaluated	O
at	O
___	O
from	O
___,	O
C.	O
diff	O
negative,	O
and	O
continued	O
diarrhea	O
over	O
the	O
weekend	O
that	O
was	O
controlled	O
with	O
Immodium.	O
In	O
ED	O
99.2	O
93	O
119/55	O
18	O
96%	O
RA	O
developed	O
fever	O
to	O
102.8	O
without	O
changes	O
in	O
other	O
vitals	O
Labs	O
were	O
significant	O
for	O
elevated	O
transaminases	O
and	O
alk	O
phos.	O
Patient	O
was	O
given	O
IVF	O
and	O
cefepime	O
for	O
neutropenic	O
fever,	O
and	O
transferred	O
to	O
the	O
floor	O
for	O
further	O
evaluation.	O
Upon	O
arrival	O
to	O
the	O
floor,	O
she	O
endorsed	O
a	O
dry	O
mouth	O
and	O
general	O
weakness	O
and	O
chills	O
but	O
had	O
no	O
other	O
complaints.	O
States	O
she	O
had	O
chills	O
for	O
at	O
least	O
the	O
past	O
week,	O
if	O
not	O
longer,	O
did	O
not	O
check	O
her	O
temperature	O
following	O
discharge	O
from	O
___	O
on	O
___.	O
Her	O
appetite	O
is	O
fair.	O
She	O
has	O
no	O
dyspnea,	O
no	O
cough,	O
no	O
chest	O
pain,	O
no	O
rashes,	O
no	O
headache,	O
no	O
myalgias	O
or	O
arthralgias.	O
No	O
sick	O
contacts.	O
Review	O
of	O
Systems:	O
(+)	O
Per	O
HPI	O
(-)	O
Denies	O
recent	O
weight	B-Weight_loss
loss	B-Weight_loss
or	O
gain.	O
Denies	O
blurry	B-Visual_impairment
vision,	B-Visual_impairment
diplopia,	B-Visual_impairment
loss	B-Visual_impairment
of	B-Visual_impairment
vision,	B-Visual_impairment
photophobia.	B-Visual_impairment
Denies	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denies	O
nausea,	O
vomiting,	O
constipation,	B-Constipation
abdominal	O
pain,	O
melena,	B-Upper_gastrointestinal_haemorrhage
hematemesis,	B-Upper_gastrointestinal_haemorrhage
hematochezia.	B-Lower_gastrointestinal_haemorrhage
Denies	O
dysuria,	O
stool	B-Faecal_incontinence
or	O
urine	B-Urinary_incontinence
incontinence.	B-Faecal_incontinence
Denies	O
rashes	O
or	O
skin	O
breakdown.	O
No	O
numbness/tingling	O
in	O
extremities.	O
All	O
other	O
systems	O
negative.	O
Past	O
Medical	O
History:	O
PAST	O
ONCOLOGIC	O
HISTORY:	O
Pancreatic	O
Cancer:	O
___-	O
presented	O
with	O
abdominal	O
pain;	O
CT	O
A/P	O
showed	O
Pancreatic	O
head	O
mass	O
measuring	O
approximately	O
41	O
x	O
37	O
mm	O
abutting	O
and	O
likely	O
encasing	O
the	O
SMA	O
and	O
partially	O
encasing	O
the	O
SMV;	O
a	O
pancreatic	O
head	O
mass	O
abutted	O
the	O
confluence	O
of	O
the	O
splenic	O
vein	O
and	O
SMV	O
with	O
thrombus	O
or	O
tumor	O
extension	O
in	O
the	O
portal	O
vein	O
with	O
dilatation	O
of	O
the	O
pancreatic	O
duct	O
within	O
the	O
body	O
and	O
tail	O
of	O
the	O
pancreas.	O
There	O
were	O
small	O
mesenteric	O
lymph	O
nodes	O
which	O
were	O
felt	O
to	O
be	O
nonspecific.	O
___-	O
EUS	O
(Dr.	O
___	O
showed	O
pancreatic	O
head	O
mass	O
with	O
cytology	O
positive	O
for	O
adenocarcinoma	O
___-	O
developed	O
biliary	O
obstruction	O
s/p	O
placement	O
of	O
stent	O
with	O
normalization	O
of	O
LFTs	O
___-	O
Diagnostic	O
laparoscopy	O
with	O
Port-A-Cath	O
placement	O
(Dr.	O
___-	O
Peritoneal	O
washings	O
negative	O
for	O
malignant	O
cells	O
___-	O
Start	O
FOLFIRINOX	O
Began	O
to	O
have	O
diarrhea	O
3	O
days	O
later,	O
took	O
imodium.	O
___	O
Admitted	O
___	O
with	O
diarrhea,	O
dehydration,	O
chest	O
pain.	O
C.	O
Diff	O
negative,	O
treated	O
with	O
fluids,	O
imodium.	O
___	O
At	O
home,	O
continued	O
to	O
have	O
diarrhea	O
but	O
less.	O
Yesterday	O
2	O
episodes,	O
controlled	O
with	O
2	O
doses	O
of	O
imodium.	O
Breast	O
Cancer:	O
___-	O
noticed	O
new	O
left	O
breast	O
mass	O
___-	O
mammogram	O
normal	O
___-	O
FNA	O
left	O
breast	O
with	O
malignant	O
cells	O
___-	O
bilateral	O
breast	O
MRIs:	O
left	O
with	O
enhancement	O
in	O
known	O
cancer	O
(extending	O
over	O
7.4	O
cm)	O
and	O
in	O
axillary	O
lymph	O
node;	O
right	O
breast	O
MRI	O
with	O
multiple	O
high-signal	O
areas	O
likely	O
representing	O
cysts,	O
as	O
well	O
as	O
intermediate-signal	O
region	O
in	O
central,	O
slightly	O
inner	O
breast;	O
u/s	O
did	O
not	O
show	O
lesion;	O
repeat	O
bilateral	O
mammogram	O
showed	O
evid	O
of	O
left	O
cancer	O
as	O
well	O
as	O
satellite	O
lesion	O
___-	O
core	O
biopsy	O
left	O
breast	O
mass	O
with	O
grade	O
III,	O
invasive	O
ductal	O
carcinoma,	O
ER/PR-positive	O
and	O
her2neu	O
negative;	O
FNA	O
left	O
axillary	O
node	O
positive	O
for	O
malignant	O
cells	O
___-	O
CT	O
C/A/P	O
with	O
small	O
lung	O
nodules;	O
multiple	O
small	O
mediastinal	O
lymph	O
nodes;	O
no	O
definite	O
evidence	O
of	O
mets;	O
bone	O
scan	O
prelim	O
negative	O
for	O
mets;	O
ECHO	O
with	O
normal	O
cardiac	O
fx	O
___-	O
started	O
dose	O
dense	O
AC	O
___-	O
taxol	O
___-	O
right	O
breast	O
lumpectomy	O
and	O
axillary	O
lymph	O
node	O
dissection	O
with	O
1.3	O
cm,	O
grade	O
III,	O
invasive	O
ductal	O
carcinoma	O
with	O
LVI	O
and	O
no	O
EIC;	O
___	O
score	O
of	O
3	O
of	O
5;	O
___	O
nodes	O
with	O
cancer;	O
ER/PR-positive	O
and	O
her2neu	O
negative.	O
___	O
Arimidex	O
___-	O
XRT	O
PAST	O
MEDICAL	O
HISTORY:	O
hyperlipidemia,	O
hiatal	O
hernia,	O
basal	O
cell	O
carcinoma,	O
osteopenia,	O
varicose	O
vein	O
surgery,	O
tonsils	O
and	O
adenoidectomy	O
in	O
childhood.	O
Social	O
History:	O
___	O
Family	O
History:	O
She	O
has	O
two	O
sons	O
in	O
their	O
___	O
who	O
are	O
cancer	O
free	O
as	O
is	O
her	O
brother	O
and	O
niece	O
and	O
nephew.	O
Her	O
mother	O
was	O
diagnosed	O
with	O
multiple	O
myeloma	O
at	O
___	O
and	O
died	O
at	O
___.	O
Her	O
other	O
had	O
two	O
sisters	O
and	O
eight	O
brothers.	O
One	O
of	O
Ms.	O
___	O
aunts	O
had	O
colon	O
cancer	O
at	O
___	O
and	O
two	O
of	O
her	O
uncles	O
had	O
prostate	O
cancer	O
at	O
older	O
ages.	O
She	O
has	O
one	O
cousin	O
with	O
lung	O
cancer	O
and	O
one	O
who	O
died	O
of	O
pancreatic	O
cancer.	O
She	O
has	O
no	O
other	O
maternal	O
history	O
of	O
cancer	O
reported.	O
On	O
her	O
fathers	O
side	O
her	O
father	O
had	O
lymphoma	O
and	O
passed	O
away	O
at	O
___.	O
He	O
had	O
four	O
sisters	O
all	O
of	O
whom	O
lived	O
into	O
their	O
___	O
with	O
no	O
cancer	O
and	O
three	O
brothers	O
who	O
were	O
also	O
cancer	O
free.	O
Ms.	O
___	O
had	O
one	O
paternal	O
cousin,	O
the	O
daughter	O
of	O
an	O
aunt,	O
who	O
died	O
in	O
her	O
___	O
from	O
ovarian	O
cancer.	O
She	O
does	O
not	O
report	O
any	O
other	O
paternal	O
history	O
of	O
cancer.	O
BRCA	O
testing	O
negative	O
Physical	O
Exam:	O
=====================	O
ADMISSION	O
EXAM	O
=====================	O
Vitals:	O
102.8	O
->	O
99	O
after	O
Tylenol	O
___	O
HR	O
109	O
->	O
90s	O
RR	O
20	O
98%	O
RA	O
GENERAL:	O
pleasant	O
female,	O
appears	O
stated	O
age,	O
no	O
distress.	O
wearing	O
dark	O
reading	O
glasses	O
because	O
other	O
glasses	O
broke	O
HEENT:	O
anicteric	O
sclerae,	O
clear	O
oropharynx,	O
no	O
exudate	O
Neck:	O
no	O
adenopathy	O
CARDIAC:	O
RRR,	O
normal	O
S1,	O
S2,	O
no	O
murmurs	O
or	O
gallops	O
Chest:	O
left	O
chest	O
port	O
without	O
erythema	O
LUNG:	O
clear	O
lungs	O
bilaterally,	O
no	O
wheezes	O
or	O
crackles	O
ABDOMEN:	O
soft,	O
non-tender,	O
slightly	O
distended,	O
active	O
bowel	O
sounds	O
EXTREMITIES:	O
2+	O
radial	O
and	O
DP	O
pulses,	O
no	O
edema	O
NEURO:	O
CNs	O
___	O
intact,	O
strength	O
and	O
sensation	O
grossly	O
intact	O
in	O
UEs	O
and	O
___	O
SKIN:	O
no	O
rashes,	O
evidence	O
of	O
tinea	O
pedis	O
on	O
feet	O
with	O
skin	O
breakdown	O
=====================	O
DISCHARGE	O
EXAM	O
=====================	O
Vitals:	O
98.3	O
130/75	O
92	O
20	O
95ra	O
GENERAL:	O
pleasant	O
female,	O
NAD	O
HEENT:	O
anicteric	O
sclerae,	O
clear	O
oropharynx,	O
no	O
exudate	O
CARDIAC:	O
RRR,	O
normal	O
S1,	O
S2,	O
no	O
murmurs	O
or	O
gallops	O
Chest:	O
left	O
chest	O
port	O
without	O
erythema	O
LUNG:	O
CTABL	O
ABDOMEN:	O
soft,	O
non-tender,	O
slightly	O
distended,	O
active	O
bowel	O
sounds	O
EXTREMITIES:	O
2+	O
radial	O
and	O
DP	O
pulses,	O
1+	O
edema	O
to	O
the	O
mid-thigh	O
NEURO:	O
AAOx3,	B-Delirium
CNs	O
___	O
intact,	O
strength	O
and	O
sensation	O
grossly	O
intact	O
SKIN:	O
no	O
rashes,	O
evidence	O
of	O
tinea	O
pedis	O
on	O
feet	O
without	O
other	O
superimposed	O
infection	O
Pertinent	O
Results:	O
=====================	O
ADMISSION	O
LABS	O
=====================	O
___	O
02:00PM	O
WBC-0.8*#	O
RBC-3.45*	O
HGB-11.1*#	O
HCT-32.8*#	O
MCV-95	O
MCH-32.1*	O
MCHC-33.8	O
RDW-12.9	O
___	O
02:00PM	O
NEUTS-0	O
BANDS-0	O
LYMPHS-80*	O
MONOS-14*	O
EOS-0	O
BASOS-0	O
ATYPS-6*	O
___	O
MYELOS-0	O
___	O
02:00PM	O
ALBUMIN-3.2*	O
___	O
02:00PM	O
LIPASE-6	O
___	O
02:00PM	O
ALT(SGPT)-45*	O
AST(SGOT)-50*	O
ALK	O
PHOS-149*	O
TOT	O
BILI-1.5	O
___	O
02:00PM	O
GLUCOSE-121*	O
UREA	O
N-8	O
CREAT-0.6	O
SODIUM-137	O
POTASSIUM-3.2*	O
CHLORIDE-104	O
TOTAL	O
CO2-22	O
ANION	O
GAP-14	O
___	O
02:04PM	O
LACTATE-2.0	O
___	O
10:00PM	O
URINE	O
MUCOUS-RARE	O
___	O
10:00PM	O
URINE	O
AMORPH-RARE	O
___	O
10:00PM	O
URINE	O
RBC-0	O
WBC-1	O
BACTERIA-FEW	O
YEAST-NONE	O
EPI-<1	O
RENAL	O
EPI-<1	O
___	O
10:00PM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-TR	O
GLUCOSE-NEG	O
KETONE-TR	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-6.5	O
LEUK-NEG	O
___	O
10:00PM	O
URINE	O
COLOR-Yellow	O
APPEAR-Clear	O
SP	O
___	O
=====================	O
DISCHARGE	O
LABS	O
=====================	O
___	O
05:30AM	O
BLOOD	O
WBC-23.9*	O
RBC-2.85*	O
Hgb-9.1*	O
Hct-28.1*	O
MCV-99*	O
MCH-31.9	O
MCHC-32.3	O
RDW-15.0	O
Plt	O
___	O
___	O
05:30AM	O
BLOOD	O
___	O
PTT-43.1*	O
___	O
___	O
05:30AM	O
BLOOD	O
Glucose-109*	O
UreaN-8	O
Creat-0.5	O
Na-140	O
K-3.4	O
Cl-107	O
HCO3-28	O
AnGap-8	O
___	O
05:30AM	O
BLOOD	O
ALT-30	O
AST-38	O
AlkPhos-235*	O
TotBili-0.7	O
___	O
05:30AM	O
BLOOD	O
Calcium-7.5*	O
Phos-2.4*	O
Mg-1.9	O
___	O
04:25PM	O
BLOOD	O
TSH-3.1	O
=====================	O
MICRO	O
=====================	O
BCX	O
-	O
NGTD,	O
drawn	O
on	O
3	O
days	O
UCx	O
-	O
final	O
no	O
growth	O
C.	O
diff	O
negative	O
Stool	O
O+P	O
negative,	O
culture	O
no	O
growth	O
=====================	O
STUDIES	O
=====================	O
RUQ	O
U/S	O
The	O
common	O
bile	O
duct	O
stent	O
in	O
place	O
with	O
minimal	O
gas	O
in	O
the	O
biliary	O
tree.	O
No	O
evidence	O
of	O
intra	O
or	O
extrahepatic	O
biliary	O
duct	O
dilatation	O
CXR:	O
Small	O
bilateral	O
pleural	O
effusions.	O
No	O
evidence	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
Brief	O
Hospital	O
Course:	O
___	O
yo	O
female	O
with	O
non-resectable	O
pancreatic	O
adenocarcinoma	O
s/p	O
FOLFIRINOX	O
with	O
neutropenic	O
fever.	O
#.	O
Neutropenic	O
fever-	O
Patient	O
met	O
SIRS	O
criteria	O
on	O
admission	O
for	O
fever,	O
tachypnea	O
and	O
tachycardia.	O
Her	O
only	O
localizing	O
symptom	O
was	O
diarrhea	O
which	O
had	O
been	O
persistent	O
for	O
1	O
week	O
and	O
which	O
had	O
a	O
negative	O
workup	O
previous	O
at	O
OSH.	O
She	O
was	O
covered	O
with	O
Vanc/Cefepime/Flagyl	O
from	O
___	O
to	O
___.	O
She	O
was	O
given	O
Neupogen	O
and	O
her	O
counts	O
recovered.	O
She	O
was	O
afebrile	O
for	O
48	O
hours	O
with	O
cultures	O
negative	O
and	O
neutropenia	O
resolved	O
and	O
antibiotics	O
were	O
stopped	O
without	O
subsequent	O
fevers.	O
She	O
developed	O
leukocytosis	O
in	O
the	O
setting	O
of	O
having	O
been	O
administered	O
Neupogen.	O
#	O
CV-r	O
:	O
Patient	O
transferred	O
to	O
the	O
ICU	O
on	O
___	O
for	O
new	O
AFib	O
with	O
RVR	O
and	O
associated	O
hemodynamic	O
instability	O
with	O
SBPs	O
in	O
___	O
after	O
being	O
given	O
Metoprolol.	O
Electrical	O
cardioversion	O
was	O
attempted	O
and	O
was	O
unsuccessful.	O
She	O
was	O
given	O
IVF	O
and	O
started	O
wtih	O
amiodarone	O
loading	O
was	O
begun	O
on	O
floor.	O
In	O
the	O
ICU,	O
she	O
was	O
continued	O
on	O
amiodarone	O
gtt.	O
This	O
resulted	O
in	O
rebound	O
in	O
blood	O
pressure	O
and	O
restoration	O
of	O
SR	O
on	O
morning	O
of	O
transfer.	O
Cardiology	O
was	O
consulted.	O
They	O
recommended	O
continuing	O
Amiodarone	O
loading.	O
She	O
was	O
started	O
on	O
metoprolol	O
25	O
mg	O
XL	O
daily.	O
Two	O
sets	O
of	O
cardiac	O
enzymes	O
and	O
TSH	O
were	O
WNL.	O
She	O
may	O
require	O
an	O
outpatient	O
TTE	O
and	O
followup	O
with	O
cardiology.	O
Anticoagulation	O
was	O
deferred	O
given	O
prognosis	O
with	O
pancreatic	O
cancer.	O
#	O
CV-p:	O
Patient	O
with	O
e/o	O
mild	O
CHF	O
in	O
the	O
setting	O
of	O
volume	O
resuscitation	O
during	O
her	O
arrhythmia.	O
She	O
was	O
diuresed	O
with	O
lasix	O
20mg	O
IV	O
successfully.	O
She	O
was	O
above	O
her	O
dry	O
weight	O
of	O
152	O
lbs,	O
weight	O
in	O
the	O
160	O
lbs	O
while	O
admitted.	O
She	O
had	O
no	O
respiratory	O
symptoms	O
but	O
still	O
had	O
significant	O
___	O
edema	O
on	O
discharge.	O
Lasix	O
should	O
be	O
continued	O
until	O
she	O
is	O
at	O
her	O
dry	O
weight	O
and	O
then	O
held	O
to	O
see	O
whether	O
her	O
weight	O
rise	O
suggesting	O
that	O
she	O
may	O
need	O
daily	O
lasix.	O
#.	O
Pancreatic	O
adenocarcinoma-	O
on	O
FOLFIRINOX,	O
started	O
___.	O
Hold	O
additional	O
therapy	O
pending	O
resolution	O
of	O
above.	O
___	O
switch	O
to	O
FOLFOX	O
or	O
Gem/Abraxane	O
as	O
outpt.	O
#.	O
Tinea	O
pedis-	O
terbinafine	O
#.	O
HL-	O
stopped	O
home	O
statin	O
#.	O
GERD-	O
PPI	O
TRANSITIONAL	O
ISSUES:	O
-	O
weigh	O
daily	O
on	O
a	O
standing	O
scale	O
-	O
continue	O
lasix	O
for	O
diuresis,	O
can	O
stop	O
giving	O
lasix	O
when	O
she	O
hits	O
her	O
dry	O
weight	O
of	O
152lbs	O
and	O
then	O
consider	O
whether	O
to	O
restart	O
based	O
on	O
whether	O
her	O
weights	O
are	O
stable	O
-	O
establish	O
outpatient	O
cardiology	O
followup	O
-	O
consider	O
TTE	O
-	O
titrate	O
loperamide	O
and	O
tincture	O
of	O
opium	O
dosing	O
to	O
___	O
BM	O
daily	O
Complete	O
Amiodarone	O
load	O
as	O
follows:	O
-	O
Amiodarone	O
200	O
mg	O
TID	O
___	O
-	O
Amiodarone	O
200	O
mg	O
BID	O
___	O
-	O
___	O
-	O
Amiodarone	O
200	O
mg	O
daily	O
___	O
onward	O
-	O
check	O
EKG	O
on	O
___,	O
if	O
QTc	O
>	O
500	O
hold	O
Amiodarone	O
and	O
contact	O
Dr.	O
___	O
further	O
instruction	O
Phone:	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
BID	O
2.	O
Atorvastatin	O
20	O
mg	O
PO	O
DAILY	O
3.	O
Omeprazole	O
20	O
mg	O
PO	O
BID	O
4.	O
Zenpep	O
(lipase-protease-amylase)	O
10,000-34,000	O
-55,000	O
unit	O
oral	O
QID	O
5.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Fluticasone	O
Propionate	O
NASAL	O
1	O
SPRY	O
NU	O
BID	O
3.	O
Omeprazole	O
20	O
mg	O
PO	O
BID	O
4.	O
Zenpep	O
(lipase-protease-amylase)	O
10,000-34,000	O
-55,000	O
unit	O
oral	O
QID	O
5.	O
Amiodarone	O
200	O
mg	O
PO	O
TID	O
Duration:	O
3	O
Days	O
-	O
Amiodarone	O
taper	O
200	O
mg	O
TID	O
___	O
200	O
mg	O
BID	O
___	O
-	O
___	O
200	O
mg	O
daily	O
___	O
onward	O
6.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
7.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
8.	O
Opium	O
Tincture	O
5	O
DROP	O
PO	O
Q6H:PRN	O
diarrhea	O
titrate	O
to	O
___	O
BM	O
daily	O
9.	O
LOPERamide	O
2	O
mg	O
PO	O
QID:PRN	O
diarrhea	O
Titrate	O
to	O
___	O
BM	O
daily	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Neutropenia	O
Fever	O
Atrial	O
fibrillation	O
with	O
rapid	O
ventricular	O
response	O
Diarrhea	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
___,	O
___	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
and	O
getting	O
to	O
you	O
know	O
at	O
___.	O
You	O
were	O
admitted	O
with	O
fevers	O
and	O
low	O
blood	O
counts.	O
You	O
were	O
given	O
broad	O
coverage	O
with	O
antibiotics	O
until	O
you	O
no	O
longer	O
had	O
fevers.	O
You	O
tested	O
negative	O
for	O
C.	O
diff	O
and	O
your	O
diarrhea	O
was	O
controlled	O
with	O
immodium	O
and	O
tincture	O
of	O
opium.	O
You	O
went	O
into	O
a	O
fast	O
heart	O
rhythm	O
with	O
low	O
blood	O
pressure	O
that	O
requries	O
you	O
take	O
several	O
new	O
medications.	O
You	O
had	O
extra	O
fluid	O
on	O
your	O
body	O
and	O
were	O
given	O
diuretics.	O
You	O
will	O
need	O
to	O
make	O
sure	O
you	O
have	O
a	O
followup	O
appointment	O
scheduled	O
with	O
cardiology.	O
Followup	O
Instructions:	O
___	O

